Tranexamic acid in hip fracture surgery: a randomized controlled trial P.J. Zufferey, M. Miquet, S. Quenet, P. Martin, P. Adam, P. Albaladejo, P. Mismetti, S. Molliex British Journal of Anaesthesia Volume 104, Issue 1, Pages 23-30 (January 2010) DOI: 10.1093/bja/aep314 Copyright © 2010 The Author(s) Terms and Conditions
Fig 1 Trial profile. #Patient could present more than one exclusion criteria. British Journal of Anaesthesia 2010 104, 23-30DOI: (10.1093/bja/aep314) Copyright © 2010 The Author(s) Terms and Conditions
Fig 2 Meta-analysis of the use of tranexamic acid compared with placebo or no treatment on the proportion of patients requiring allogeneic red blood cell transfusion. *Double-blinded randomized study, surgery performed within 24 h after hip fracture, 15 mg kg−1 of i.v. tranexamic acid was given just once before surgery. British Journal of Anaesthesia 2010 104, 23-30DOI: (10.1093/bja/aep314) Copyright © 2010 The Author(s) Terms and Conditions